Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins Medicine
Baltimore, MD
Accepting patients
CA057-003
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
- CELMoD
- Phase 1/2
- Has results